Novartis Wins Herpes Drug Patent Fight Against Teva
A jury has sided with Novartis AG in a suit it filed claiming Teva Pharmaceuticals USA Inc. infringed the patent for its genital herpes drug Famvir by seeking regulatory approval to...To view the full article, register now.
Already a subscriber? Click here to view full article